admitted Thursday that problems with its human blood substitute Hemopure are forcing it to delay filing an approval application with U.S. drug regulators for at least six months. also reported that a ...

Howard Richman better hope there's no such thing as karma. The former BioPure vice president was sentenced last month to three years in prison for faking cancer to avoid an SEC investigation. The ...

CAMBRIDGE, Mass., Dec. 17 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that it has submitted to the Food and Drug Administration (FDA ...

BioPure’s new site will increase provision of vital fluid components to the biopharmaceutical industry The facility is five times the size of BioPure’s previous location Product consistency and ...

and its faulty experimental blood substitute Hemopure, I've been most surprised about one thing: the capacity for some investors to remain bullish despite the weight of evidence to the contrary. After ...

BOSTON -- A former executive of Biopure Corp. pleaded guilty Wednesday to an obstruction of justice charge for pretending he had terminal cancer and admitted he had impersonated his own doctor to ...

KINGSPORT, Tenn. (WJHL) – Stronger together. A Tri-Cities business giving back in the midst of COVID-19. bioPURE, a Johnson City-based disinfectant company treated Second Harvest Food Bank in ...

LONDON (MarketWatch) -- Biopure Corp. said it's received a provisional opinion letter from the U.K. Commission on Human Medicines containing comments and questions based on the company's marketing ...